Searched for
T R GOVINDARAJAN
Eicher Motors shares in focus after Royal Enfield forays into electric bike segmentEicher Motors' Royal Enfield launches its first electric motorcycle, the Flying Flea C6, marking entry into the EV space. The bike features...- Royal Enfield unveils The Flying Flea C6: A new era of electric motorcyclesRoyal Enfield unveiled its first electric motorcycle, The Flying Flea C6, under a new brand. Set to launch in spring 2026, the premium-pric...
- Demonte Colony 2 OTT release date out: Where and when to watch Arulnithi's horror-thriller. Check plot, castDemonte Colony 2, the sequel to the 2015 Tamil horror hit, was released in theaters on August 15 and stars Arulnithi Tamilarasu and Priya B...
- Vikram-starrer 'Cobra' to get a theatrical release on August 31The Tamil-language action thriller is written and directed by R Ajay Gnanamuthu.
- South star Vikram's 'Cobra' to release in theatres on August 11The film features an ensemble cast including Srinidhi Shetty and former cricketer Irfan Pathan.
- Perfios to acquire fintech platform Karza for Rs 600 crorePerfios earlier last month raised around Rs 520 crore from Warburg Pincus and Bessemer, and some of the existing investors. It will use the...
- Aurobindo Pharma Q2 results: Net profit drops 2.1% YoY to Rs 697 croreRevenues declined 2.1 per cent to Rs 5942 crore in Q2FY22 compared to the previous year's Rs 6069 crore.
- Aurobindo Pharma plans to launch 50-60 products in US in FY21The company has received final approval for six ANDAs (abbreviated new drug application) and launched four products in the fourth quarter o...
- Aurobindo Pharma lines up $200 million capex for FY20Aurobindo Pharma Ltd. to invest $ 200 million on Capex and over 5% of sale value on R&D.
- Sell Aurobindo Pharma Ltd. target Rs 568 : Dr CK NarayanSell Aurobindo Pharma Ltd. at a price target of Rs 568.0 and a stoploss at Rs 585.0 from entry point
- Buy Aurobindo Pharma, target Rs 660: Kunal BothraBuy Aurobindo Pharma Ltd. at a price target of Rs 660 and a stop loss at Rs 585.0 from entry point
- Sell Aurobindo Pharma, target Rs 500.0 : Edelweiss Financial ServicesSell Aurobindo Pharma Ltd. at a price target of Rs 500 and a stop loss at Rs 630.0 from entry point
- Buy Aurobindo Pharma with a target of Rs 660 -- Kunal BothraBuy Aurobindo Pharma Ltd. at a price target of Rs 660.0 and a stop loss at Rs 600.0 from entry point
- Narayana Murthy gets support from US experts, thinkersMurthy on Sunday had said that in a poor country like India, every senior management person of an Indian corporation has to show self-restr...
- Use of race in political party's name not objectionable: ECThe EC produced a September 15, 2015 communication to the effect that the name of a caste is not allowed to be used with the name of a poli...
- Govt policies do not ensure returns in the short term: Govindarajan Chellappa, Jefferies IndiaIn a chat with Nikunj Dalmia of ET Now, Govindarajan Chellappa, HoR, Jefferies India (by Nikunj Dalmia) explains how linkage between commod...
- India will do better than rest of the emerging markets: Govindarajan Chellappa, Jefferies IndiaIn a chat with ET Now, Govindarajan Chellappa, HoR, Jefferies India, talks about how commodity prices are affecting stockmarkets
- Prime Minister should make a strong statement: T R Govindarajan"Ministers who make extreme remarks should be warned, and this should be a strong signal from the government, particularly the Prime Minist...
- Chennai Petro inks MoU with TII to implement integrity pactIn a bid to maintain complete transparency in contracts and procurements, Chennai Petroleum Corporation (CPCL) has signed a MoU with Transp...
- Inclusive growth through more jobs in BharatThe National Manufacturing Competitiveness Council (NM-CC) will urge the government to devise policies to ensure that economic growth, espe...
Load More
